Metabonomics research of diabetic nephropathy and type 2 diabetes mellitus based on UPLC-oaTOF-MS system

被引:105
|
作者
Zhang, Jie [1 ]
Yan, Lijuan [2 ]
Chen, Wengui [3 ]
Lin, Lin [1 ]
Song, Xiuyu [3 ]
Yan, Xiaomei [1 ]
Hang, Wei [1 ]
Huang, Benli [1 ]
机构
[1] Xiamen Univ, Coll Chem & Chem Engn, Key Lab Chem Biol Fujian Province, Xiamen 361005, Peoples R China
[2] XiaMen Entry Exit Inspect & Quarantine Bur, Xiamen 361012, Peoples R China
[3] First Hosp Xiamen, Xiamen 361003, Peoples R China
基金
中国博士后科学基金; 中国国家自然科学基金;
关键词
Diabetic nephropathy; Diabetes mellitus; Metabonomics; Ultra performance liquid chromatography; Time-of-flight mass spectrometry; MASS-SPECTROMETRY; H-1-NMR METABONOMICS; PLASMA; ZUCKER; RAT; CERAMIDE; PROFILE; URINE; AGE; ELUCIDATION;
D O I
10.1016/j.aca.2009.02.027
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Ultra performance liquid chromatography (UPLC) coupled with orthogonal acceleration time-of-flight (oaTCF) mass spectrometry has showed great potential in diabetes research. In this paper, a UPLC-oaTOF-MS system was employed to distinguish the global serum profiles of 8 diabetic nephropathy (DN) patients, 33 type 2 diabetes mellitus (T2DM) patients and 25 healthy volunteers,and tried to find potential biomarkers. The UPLC system produced information-rich chromatograms with typical measured peak widths of 4s, generating peak capacities of 225 in 15 min. Furthermore, principal component analysis (PCA) was used for group differentiation and marker selection. As shown in the scores plot, the distinct clustering between the patients and controls was observed, and DN and T2DM patients were also separated into two individual groups. Several compounds were tentatively identified based on accurate mass, isotopic pattern and MS/MS information. In addition, significant changes in the serum level of leucine, dihydrosphingosine and phytoshpingosine were noted, indicating the perturbations of amino acid metabolism and phospholipid metabolism in diabetic diseases, which having implications in clinical diagnosis and treatment. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:16 / 22
页数:7
相关论文
共 50 条
  • [1] Metabonomics Research of Diabetes Mellitus and Diabetic Nephropathy Based on UPLC-oaTOF-MS System
    Zhang Jie
    Yan Li-Juan
    Lin Lin
    Chen Wen-Gui
    Song Xiu-Yu
    Yan Xiao-Mei
    Hang Wei
    Huang Ben-Li
    CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE, 2008, 29 (11): : 2171 - 2173
  • [2] Preliminary observational study of metabonomics in patients with early and late-onset type 2 diabetes mellitus based on UPLC-Q-TOF/MS
    Zhaohu Hao
    Junxin Yao
    Xiaoying Zhao
    Ran Liu
    Baocheng Chang
    Hailin Shao
    Scientific Reports, 13
  • [3] Preliminary observational study of metabonomics in patients with early and late-onset type 2 diabetes mellitus based on UPLC-Q-TOF/MS
    Hao, Zhaohu
    Yao, Junxin
    Zhao, Xiaoying
    Liu, Ran
    Chang, Baocheng
    Shao, Hailin
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [4] Thyroid Function In Type 2 Diabetes Mellitus and in Diabetic Nephropathy
    Rai, Srinidhi
    Kumar, Ashok J.
    Prajna, K.
    Shety, Shobith Kumar
    Rai, Tirthal
    Shrinidhi
    Begum, Mohamedi
    Shashikala
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2013, 7 (08) : 1583 - 1585
  • [5] Progress in Metabonomics of Type 2 Diabetes Mellitus
    Ma, Quantao
    Li, Yaqi
    Wang, Min
    Tang, Ziyan
    Wang, Ting
    Liu, Chenyue
    Wang, Chunguo
    Zhao, Baosheng
    MOLECULES, 2018, 23 (07):
  • [6] THE CONCORDANCE BETWEEN DIABETIC NEPHROPATHY AND RETINOPATHY IN TYPE 2 DIABETES MELLITUS
    Rajiv, A.
    NEPHROLOGY, 2016, 21 : 58 - 58
  • [7] THE CORRELATION BETWEEN DEPRESSION AND DIABETIC NEPHROPATHY IN TYPE 2 DIABETES MELLITUS
    Themeli, Y.
    Aliko, I.
    Hashorva, A.
    Bajrami, V.
    Idrizi, A.
    Barbullushi, M.
    Ktona, E.
    EUROPEAN PSYCHIATRY, 2012, 27
  • [8] Progression of diabetic nephropathy in Saudi patients with type 2 diabetes mellitus
    Al Suleiman, Mohamed H.
    Kfoury, Hala K.
    Jondeby, Mohamed S.
    Burgos, Noel S.
    Al Hayyan, Hajjar
    Al Sayyari, Abdulla
    ENDOCRINOLOGIST, 2008, 18 (05): : 230 - 232
  • [9] Monoclonal Antibody Pharmacokinetics in Type 2 Diabetes Mellitus and Diabetic Nephropathy
    Chadha G.S.
    Morris M.E.
    Current Pharmacology Reports, 2016, 2 (2) : 45 - 56
  • [10] Diabetic nephropathy in a nonobese mouse model of Type 2 diabetes mellitus
    Mallipattu, Sandeep K.
    Gallagher, Emily J.
    LeRoith, Derek
    Liu, Ruijie
    Mehrotra, Anita
    Horne, Sylvia J.
    Chuang, Peter Y.
    Yang, Vincent W.
    He, John C.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2014, 306 (09) : F1008 - F1017